Inhibition of hepatic Sulf2 in vivo: a novel strategy to correct diabetic dyslipidemia

BACKGROUND: Type 2 diabetes mellitus (T2DM) impairs hepatic clearance of atherogenic postprandial triglyceride-rich lipoproteins (TRL). We recently reported that livers from T2DM db/db mice markedly overexpress glucosamine-6-O-endosulfatase-2 (SULF2), an enzyme that removes 6-O sulfate groups from h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hassing, H.C., Mooij, H., Guo, S., Monia, B.P., Chen, Keyang, Kulik, W., Dallinga-Thie, G.M., Nieuwdorp, M., Stroes, E.S.G., Williams, K.J.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3345297/
https://ncbi.nlm.nih.gov/pubmed/22234891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.25580
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars